Could a platelet booster keep chemotherapy on track for breast cancer patients?
NCT ID NCT07771881
First seen Aug 18, 2026 · Last updated Aug 18, 2026
Summary
This phase 2 trial is testing whether romiplostim, a drug that stimulates platelet production, can prevent chemotherapy-induced thrombocytopenia (low platelet counts) in breast cancer patients. The study enrolls adults aged 18 to 75 with breast cancer who experienced low platelets after a previous chemotherapy cycle. Participants receive romiplostim injections weekly, with doses adjusted based on platelet counts, to see if it can maintain platelet levels and reduce the need for treatment delays or dose reductions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Romiplostim N01 for injection
- What this could lead to
- If effective, this could offer a way to prevent severe platelet drops in breast cancer patients, reducing bleeding risks and avoiding chemotherapy delays or dose reductions.
- What could go wrong
- This is an early-phase study with a small number of participants, so results may not apply broadly. Romiplostim can have side effects, and its long-term safety in this setting is not yet fully known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI coach aims to ease life after breast cancer
- Can tape or a pressure vest ease Post-Radiation breast swelling?
- Can a new pill keep HER2-Positive breast cancer from coming back?
- Personalized chemo: could tumor DNA hold the key to better breast cancer treatment?
- Can AI craft the perfect exercise plan for breast cancer survivors?
- Vitamin d gel on the scalp: a new hope against chemo hair loss?